EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Energy transfer ratio as a metric of right ventricular efficiency in repaired congenital heart disease


Congenital Heart Disease 8(4): 328-342
Energy transfer ratio as a metric of right ventricular efficiency in repaired congenital heart disease
With the success of early repair, continued functional assessment of repaired congenital heart disease is critical for improved long-term outcome. Pulmonary regurgitation, which is one of the main postoperative sequelae of congenital heart disease involved with the right ventricle (RV) such as tetralogy of Fallot and transposition of the great arteries, results in progressive RV dilatation coupled with pulmonary artery (PA) obstruction causing elevated RV pressures. The appropriate timing of intervention to correct these postoperative lesions remains largely subjective. In the present study, we evaluated an energy-based end point, namely energy transfer ratio (eMPA), to assess the degree of RV and PA inefficiency in a group of congenital heart disease patients with abnormal RV-PA physiology. Eight patients with abnormal RV-PA physiology and six controls with normal RV-PA physiology were investigated using a previously validated technique that couples cardiac magnetic resonance imaging and invasive pressure measurements. The mean eMPA of the patient group (0.56 0.33) was significantly lower (P <.04) than that of the control group (1.56 0.85), despite the fact that the patient group had a significantly higher RV stroke work indexed to body surface area (RV SWI) than the control group (0.205 0.095?J/m2 vs. 0.090 0.038?J/m2; P <.02). We determined that the patients had inefficient RV-PA physiology due to a combination of RV dilatation with pulmonary regurgitation and RV outflow obstruction leading to an elevated end-systolic pressure. Using coupled magnetic resonance imaging and invasive pressure measurements, eMPA is determined to be a sensitive energy-based end point for measuring RV-PA efficiency. It may serve as a diagnostic end point to optimize timing of intervention.

(PDF same-day service: $19.90)

Accession: 036735779

PMID: 23331703

DOI: 10.1111/chd.12034



Related references

Ventricular tachycardia in repaired congenital heart disease. Herzschrittmachertherapie & Elektrophysiologie 27(2): 131-136, 2016

Late potentials and inducible ventricular tachycardia in surgically repaired congenital heart disease. Circulation 82(5): 1690-1696, 1990

Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circulation. Arrhythmia and Electrophysiology 8(1): 102-109, 2015

Anatomical Substrates and Ablation of Reentrant Atrial and Ventricular Tachycardias in Repaired Congenital Heart Disease. Arrhythmia & Electrophysiology Review 5(2): 150-160, 2016

Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease. Heart Rhythm 13(7): 1449-1454, 2016

Optimizing paced ventricular function in patients with and without repaired congenital heart disease by contractility-guided lead implant. Pacing and Clinical Electrophysiology 38(1): 54-62, 2015

Pulmonary valve replacement improves but does not normalize right ventricular mechanics in repaired congenital heart disease: a comparative assessment using velocity vector imaging. Journal of the American Society of Echocardiography 21(11): 1216-1221, 2008

Impact of right ventricular pacing on three-dimensional global left ventricular dyssynchrony in children and young adults with congenital and acquired heart block associated with congenital heart disease. American Journal of Cardiology 104(5): 700-706, 2009

Pathophysiology and management of heart failure in repaired congenital heart disease. Heart Failure Clinics 6(4): 497-506, Ix, 2011

Mechanical circulatory support for end-stage heart failure in repaired and palliated congenital heart disease. Current Cardiology Reviews 7(2): 102-109, 2013